Chimerix Stock Today
| CMRX Stock | USD 8.46 0.01 0.12% |
PerformanceSolid
| Odds Of DistressBelow Average
|
Chimerix is trading at 8.46 as of the 16th of March 2025; that is 0.12 percent decrease since the beginning of the trading day. The stock's open price was 8.47. Chimerix has about a 31 percent probability of financial distress in the next few years of operation but had a somewhat solid performance during the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina. Chimerix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 93.05 M outstanding shares of which 4.14 M shares are currently shorted by private and institutional investors with about 2.65 trading days to cover. More on Chimerix
Moving against Chimerix Stock
Chimerix Stock Highlights
| President CEO | Michael MBA |
| Thematic Idea | Biotech (View all Themes) |
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Biotech, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
| Financial Strength | |
Chimerix (CMRX) is traded on NASDAQ Exchange in USA. It is located in 2505 Meridian Parkway, Durham, NC, United States, 27713 and employs 72 people. Chimerix is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 787.18 M. Chimerix conducts business under Biotechnology sector and is part of Health Care industry. The entity has 93.05 M outstanding shares of which 4.14 M shares are currently shorted by private and institutional investors with about 2.65 trading days to cover.
Chimerix currently holds about 42.79 M in cash with (69.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.49.
Check Chimerix Probability Of Bankruptcy
Ownership AllocationChimerix holds a total of 93.05 Million outstanding shares. Over half of Chimerix's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Chimerix Ownership Details
Chimerix Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Chimerix market risk premium is the additional return an investor will receive from holding Chimerix long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.1972 | |||
| Jensen Alpha | 1.99 | |||
| Total Risk Alpha | 3.33 | |||
| Sortino Ratio | 0.632 |
Chimerix Stock Against Markets
Chimerix Corporate Management
| MD MBA | Chief Officer | Profile | |
| David CPA | Exec Officer | Profile | |
| Joshua Allen | Chief Imipridones | Profile | |
| Dr MBA | Chief Officer | Profile | |
| Pablo MD | Head Affairs | Profile |
Additional Tools for Chimerix Stock Analysis
When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.